scholarly journals The Feasibility of postpyloric feeding tube placement in thrombocytopenic +/‐ anticoagulated patients on the intensive care unit CORTRAK in thrombocytopenic patients

Author(s):  
Stephanie‐Susanne Stecher ◽  
Michaela Barnikel ◽  
Heidrun Drolle ◽  
Alexandra Pawlikowski ◽  
Johanna Tischer ◽  
...  

2011 ◽  
Vol 26 (4) ◽  
pp. 411-414 ◽  
Author(s):  
Arnaud Galbois ◽  
Paola Vitry ◽  
Hafid Ait-Oufella ◽  
Jean-Luc Baudel ◽  
Bertrand Guidet ◽  
...  


Burns ◽  
2011 ◽  
Vol 37 (2) ◽  
pp. 277-280 ◽  
Author(s):  
S.J. Hemington-Gorse ◽  
N.N. Sheppard ◽  
R. Martin ◽  
O. Shelley ◽  
B. Philp ◽  
...  


2001 ◽  
Vol 48 (7) ◽  
pp. 705-710 ◽  
Author(s):  
A. Shawn Kindopp ◽  
John W. Drover ◽  
Daren K. Heyland




2021 ◽  
Vol 9 ◽  
Author(s):  
Sirima Ketsuwan ◽  
Pornthep Tanpowpong ◽  
Nichanan Ruangwattanapaisarn ◽  
Supatra Phaopant ◽  
Nattanicha Suppalarkbunlue ◽  
...  

Objective: Impaired gastric emptying is a common cause of delayed feeding in critically ill children. Post-pyloric feeding may help improve feeding intolerance and nutritional status and, hence, contribute to a better outcome. However, post-pyloric feeding tube insertion is usually delayed due to a technical difficulty. Therefore, prokinetic agents have been used to facilitate blind bedside post-pyloric feeding tube insertion. Metoclopramide is a potent prokinetic agent that has also been used to improve motility in adults and children admitted to intensive care units. The objective of this study was to determine the efficacy of intravenous metoclopramide in promoting the success rate of blind bedside post-pyloric feeding tube placement in critically ill children.Design: The design of this study is randomized, double blind, placebo controlled.Setting: The setting of the study is a single-center pediatric intensive care unit.Patients: Children aged 1 month−18 years admitted to the pediatric intensive care unit with severe illness or feeding intolerance were enrolled in this study.Intervention: Patients were randomly selected to receive intravenous metoclopramide or 0.9% normal saline solution (the placebo) prior to the tube insertion. The study outcome was the success rate of post-pyloric feeding tube placement confirmed by an abdominal radiography 6–8 h after the insertion.Measurements and Main Results: We found that patients receiving metoclopramide had a higher success rate (37/42, 88%) of post-pyloric feeding tube placement than the placebo (28/40, 70%) (p = 0.04). Patients who received sedative drug or narcotic agent showed a tendency of higher success rate (p = 0.08).Conclusion: Intravenous metoclopramide improves the success rate of blind bedside post-pyloric placement of feeding tube in critically ill children.Trial Registration: Thai Clinical Trial Registry TCTR20190821002. Registered 15th August 2019.





Author(s):  
Holly Catherine Gillis ◽  
Ada Lin ◽  
Kenneth Jackson ◽  
Claire Stewart


2020 ◽  
Vol 29 (21) ◽  
pp. 1277-1281
Author(s):  
Stephen Taylor ◽  
Alex Manara ◽  
Jules Brown ◽  
Kaylee Sayer ◽  
Rowan Clemente ◽  
...  

Electromagnetic (EM) guided enteral tube placement may reduce lung misplacement to almost zero in expert centres, but more than 60 undetected misplacements had occurred by 2016 resulting in major morbidity or death. Aim: Determine the accuracy of manufacturer guidance in trace interpretation against what is referred to as the ‘GI flexure system’. Methods: The authors prospectively observed the accuracy of the ‘GI flexure system’ of trace interpretation against manufacturer guidance in primary nasointestinal (NI) tube placements. Findings: Contrary to manufacturer guidance, 33% of traces deviated >5 cm from the sagittal midline and 26.5% were oesophageal when entering the lower left quadrant, incorrectly indicating lung and gastric placement, respectively. Conversely, the GI flexure system identified ≥99.4% of GI traces when they reached the gastric body flexure; 100% at the superior duodenal flexure. All lung misplacements were identified by the absence of GI flexures. Conclusion: Current manufacturer guidance should be updated to the GI flexure system of interpretation.





Sign in / Sign up

Export Citation Format

Share Document